ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 18300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 18300; 2) Community: the network communities that were significantly associated with the response to NSC 18300; 3) Molecule: the relationships between components within communities and NSC 18300; 4) MDR: the compounds that were significantly associated with the NSC 18300.

NSC Compound Enrichment Correlation
NSC 715407 Null 0.0237269271456697 0.42140071
NSC 717468 Null 0.0237269271456697 0.40349269
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0237269271456697 0.41520683
NSC 752346 Null 0.0237269271456697 0.016417543
NSC 752761 Null 0.0237269271456697 -0.059827231
NSC 756483 SB-742864 0.0237269271456697 0.33382823
NSC 758670 TANNIC ACID 0.0237269271456697 -0.19849507
NSC 287069 Epicorazine A 0.0291420747327558 0.35458655
NSC 295499 Camptothecin Derivative 0.0291420747327558 0.29983193
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.0291420747327558 0.108246
Total:82  Current:48    [First] [Prev] [Next] [Last]